D.L. Carlson Investment Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-16,485
Closed -$4.01M 139
2017
Q2
$4.01M Sell
16,485
-416
-2% -$97.8K 1.18% 33
2017
Q1
$4.04M Buy
16,901
+355
+2% +$82.7K 1.37% 23
2016
Q4
$3.48M Buy
16,546
+319
+2% +$66.1K 1.18% 27
2016
Q3
$3.74M Buy
16,227
+289
+2% +$70.6K 1.3% 27
2016
Q2
$3.68M Buy
15,938
+6,895
+76% +$1.59M 1.31% 27
2016
Q1
$2.42M Buy
9,043
+97
+1% +$27.8K 0.9% 54
2015
Q4
$2.8M Buy
8,946
+2,066
+30% +$615K 1.04% 37
2015
Q3
$1.87M Sell
6,880
-510
-7% -$157K 0.76% 56
2015
Q2
$2.24M Sell
7,390
-990
-12% -$295K 0.81% 55
2015
Q1
$2.49M Buy
8,380
+5,110
+156% +$1.46M 0.89% 43
2014
Q4
$842K Buy
+3,270
New +$817K 0.3% 101

Other funds holding AGN

D.L. Carlson Investment Group's AGN Position: Q3 2017 in Review

D.L. Carlson Investment Group sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 16,485 shares — an estimated $4.01M sold.

D.L. Carlson Investment Group first reported a position in AGN in Q4 2014 and held it in 11 quarters. The position peaked at $4.04M in Q1 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • D.L. Carlson Investment Group reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • D.L. Carlson Investment Group sold 16,485 Allergan plc shares in Q3 2017, an estimated $4.01M.
  • D.L. Carlson Investment Group first reported a position in Allergan plc in Q4 2014 and held it in 11 quarters.
  • D.L. Carlson Investment Group's Allergan plc position peaked at $4.04M in Q1 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on D.L. Carlson Investment Group's 13F filing for Q3 2017, filed 13 Nov 2017.